101 assets in Metastatic Malignant Neoplasm In The Brain

Therapeutic assets addressing Metastatic Malignant Neoplasm In The Brain, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Trastuzumab Metastatic Malignant Neoplasm In The Brain	Iambic Therapeutics, Inc	P4	BB (68)
Trastuzumab Deruxtecan Metastatic Malignant Neoplasm In The Brain	Baptist Health South Florida	P4	BB (66)
Capecitabine Metastatic Malignant Neoplasm In The Brain	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P3	BB (65)
Copper Cu 64-Dota-Trastuzumab Metastatic Malignant Neoplasm In The Brain	City of Hope Medical Center	P4	BB (65)
Memantine Metastatic Malignant Neoplasm In The Brain	NRG Oncology	P3	BB (64)
Regorafenib Metastatic Malignant Neoplasm In The Brain	Neonc Technologies, Inc.	P2	BB (64)
Irinotecan Metastatic Malignant Neoplasm In The Brain	Tianjin Medical University Cancer Institute and Hospital	P3	B (63)
Zorifertinib Metastatic Malignant Neoplasm In The Brain	Alpha Biopharma (Jiangsu) Co., Ltd.	P2/3	B (63)
Carboplatin Metastatic Malignant Neoplasm In The Brain	Fudan University	P2	B (62)
Cyclophosphamide Metastatic Malignant Neoplasm In The Brain	City of Hope Medical Center	P2	B (62)
Ipilimumab Metastatic Malignant Neoplasm In The Brain	Stanford University	P3	B (62)
Nivolumab Metastatic Malignant Neoplasm In The Brain	Stanford University	P3	B (62)
Pembrolizumab Metastatic Malignant Neoplasm In The Brain	City of Hope Medical Center	P2	B (61)
Abemaciclib Metastatic Malignant Neoplasm In The Brain	H. Lee Moffitt Cancer Center and Research Institute	P2	B (60)
Atezolizumab Metastatic Malignant Neoplasm In The Brain	National Cancer Institute (NCI)	P2	B (60)
Carvedilol Metastatic Malignant Neoplasm In The Brain	SWOG Cancer Research Network	P3	B (60)
Memantine Hydrochloride Metastatic Malignant Neoplasm In The Brain	NRG Oncology	P3	B (60)
Ribociclib Metastatic Malignant Neoplasm In The Brain	Nationwide Children's Hospital	P2	B (60)
Tucidinostat Metastatic Malignant Neoplasm In The Brain	HUYABIO International, LLC.	P3	B (60)
Vinorelbine Ditartrate Metastatic Malignant Neoplasm In The Brain	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	B (60)
Dexasone Metastatic Malignant Neoplasm In The Brain	The Second Affiliated Hospital of Hainan Medical University	P2/3	B (59)
Famitinib Metastatic Malignant Neoplasm In The Brain	Fudan University	P3	B (59)
Lorlatinib Metastatic Malignant Neoplasm In The Brain	Guangdong Association of Clinical Trials	P4	B (59)
Osimertinib Metastatic Malignant Neoplasm In The Brain	Fudan University	P3	B (59)
Paclitaxel Trevatide Metastatic Malignant Neoplasm In The Brain	Angiochem Inc	P3	B (59)
Cabozantinib Metastatic Malignant Neoplasm In The Brain	Memorial Sloan Kettering Cancer Center	P2	B (58)
Cis-Diamminedichloroplatinum Ii Metastatic Malignant Neoplasm In The Brain	Fudan University	P3	B (58)
Durvalumab Metastatic Malignant Neoplasm In The Brain	University of Texas Southwestern Medical Center	P2	B (58)
Tucatinib Metastatic Malignant Neoplasm In The Brain	Baptist Health South Florida	P2	B (58)
Encorafenib Metastatic Malignant Neoplasm In The Brain	University of Utah	P2	CCC (55)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide Metastatic Malignant Neoplasm In The Brain	Peking University Cancer Hospital & Institute	P2	CCC (55)
Paxalisib Metastatic Malignant Neoplasm In The Brain	Memorial Sloan Kettering Cancer Center	P2	CCC (55)
Pertuzumab Metastatic Malignant Neoplasm In The Brain	Carey Anders, M.D.	P2	CCC (55)
Pyrotinib Metastatic Malignant Neoplasm In The Brain	Fudan University	P2	CCC (55)
Relatlimab Metastatic Malignant Neoplasm In The Brain	Stanford University	P2	CCC (55)
Serplulimab Metastatic Malignant Neoplasm In The Brain	Sun Yat-sen University	P2/3	CCC (55)
T-Dxd Metastatic Malignant Neoplasm In The Brain	Iambic Therapeutics, Inc	P2	CCC (55)
Trastuzumab Emtansine Metastatic Malignant Neoplasm In The Brain	M.D. Anderson Cancer Center	P2	CCC (55)
Dabrafenib Metastatic Malignant Neoplasm In The Brain	Mayo Clinic	P2	CCC (54)
Rvp-001 Metastatic Malignant Neoplasm In The Brain	Reveal Pharmaceuticals Inc.	P2	CCC (54)
ty-9591 Metastatic Malignant Neoplasm In The Brain	TYK Medicines, Inc	P2	CCC (54)
Adagrasib Metastatic Malignant Neoplasm In The Brain	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adebrelimab Metastatic Malignant Neoplasm In The Brain	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CCC (53)
Binimetinib Metastatic Malignant Neoplasm In The Brain	UNICANCER	P2	CCC (53)
Entrectinib Metastatic Malignant Neoplasm In The Brain	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Everolimus Metastatic Malignant Neoplasm In The Brain	Nationwide Children's Hospital	P2	CCC (53)
HER3 Dendritic Cell Vaccine Metastatic Malignant Neoplasm In The Brain	Roswell Park Cancer Institute	P2	CCC (53)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Metastatic Malignant Neoplasm In The Brain	City of Hope Medical Center	P2	CCC (53)
Ivonescimab Metastatic Malignant Neoplasm In The Brain	Fudan University	P2	CCC (53)
jk-1201i Metastatic Malignant Neoplasm In The Brain	JenKem Technology Co., Ltd.	P2	CCC (53)

Showing 1 to 50 of 101 assets

PreviousPage 1 of 3Next